Privia Health Group, Inc. (PRVA)

In the past six months, Privia Health Group, Inc. reported its Fourth Quarter and Full-Year 2025 financial results on February 26, 2026, which included beating revenue and EPS expectations. The First Quarter 2026 financial results reported on May 7, 2026, where the company again beat Wall Street's revenue expectations with a 25.8% year-on-year growth, though adjusted EPS missed analyst estimates. Insider trading activity has also been noted, with multiple insider share sales reported in early May 2026. The stock has experienced volatility, with a 3.5% decline over the 7 days leading up to May 9, 2026, but a 7.2% gain over the preceding 30 days, and a year-to-date return of 2.3% against a 4.3% loss over the past year. The stock's negative reaction to the Q1 2026 earnings reflected investor disappointment that operational improvements had not yet translated to bottom-line profitability as expected.

Privia Health Group, Inc. experiences demand seasonality, particularly impacting its cash flows. The first quarter typically sees seasonally pressured cash flows due to payments made to providers and employees. While the company generally expects a strong conversion of EBITDA to free cash flow, year-end cash figures can be heavily influenced by the timing and size of acquisition activities.

Privia Health Group, Inc. is a national physician-enablement company that operates in the Healthcare sector, specifically in the Health Information Services industry. The company collaborates with medical groups, health plans, and health systems to enhance physician practices, improve patient experiences, and reward healthcare providers for delivering high-value care in both in-person and virtual settings. Privia Health's core offering is the Privia Platform, an extensive suite of technology and service solutions that supports population health management, optimizes practice operations, and improves performance in value-based care models. The company also provides management services organizations (MSOs) to reduce administrative burdens for providers and operates a single-TIN medical group to facilitate negotiating power and clinical integration. Additionally, Privia Health manages accountable care organizations (ACOs) to engage patients, reduce inappropriate utilization, and enhance care coordination and quality metrics, driving value-based care.

Privia Health Group, Inc. has a significant geographic presence across the United States, operating in approximately 24 states and the District of Columbia. Its headquarters are located in Arlington, Virginia. The company's market strategy follows a hub-and-spoke model, with established core markets in the Mid-Atlantic region (Virginia, Maryland, and D.C.) and the Southeast (Georgia). Privia Health has been actively expanding its footprint, with notable growth in states such as Texas, Florida, and the Midwest, particularly in areas with large Medicare Advantage populations that align with its value-based care focus. As of early 2026, Privia Health has also entered the Arizona market.

In the past year, Privia Health Group, Inc. has maintained a positive brand reputation, marked by industry recognition and strong operational metrics. The company earned the 2026 HFMA MAP Award for Revenue Cycle Excellence, an honor it has received in nine of the past ten years. Furthermore, Privia Health has reported very high gross provider retention and a high patient Net Promoter Score across its footprint, indicating strong satisfaction among both its healthcare providers and patients. There were no significant negative events or controversies affecting Privia Health Group, Inc.'s reputation found in the past year's search results.

Privia Health Group, Inc. is predominantly owned by institutional investors, including The Vanguard Group, BlackRock, Inc., and T. Rowe Price. While institutional investors hold the largest blocks of shares, founders and executives retain meaningful stakes that influence governance and strategy. Pamplona Capital Management LLC is noted as a significant individual shareholder. Overall, institutional investors hold approximately 94.48% of the stock, while insiders hold about 5.70%.